Skip to main content
IMRX logo

Immuneering Corporation

IMRXNASDAQHealthcareBiotechnology

$3.64Today:- (-)1Y −34.30%

As of Oct 15, 2026 close

Market cap
$235.50M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.41$8.48
Volume (live)
-
Avg. volume (3M)
750.59K

Immuneering (IMRX) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Immuneering had return on equity of -43.1% (up from -92.5%), debt-to-equity of 0.02 (down from 0.10), a current ratio of 17.50 (up from 5.28) and return on assets of -26.1% (up from -51.6%). A current ratio of 17.50 means current assets exceed current liabilities.

Immuneering Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio---404.05204.62-
P/B Ratio1.951.652.381.172.73-
Price/Tangible Book2.011.992.581.252.86-
Enterprise Value Ratios
EV/Revenue---49.59128.17-
Profitability & Returns
Return on Equity (ROE)-43.12%-92.51%-53.36%-38.00%-35.00%-74.56%
Return on Assets (ROA)-26.07%-51.57%-32.46%-22.37%-20.65%-40.66%
Return on Capital Employed (ROCE)-26.80%-141.70%-61.70%-45.30%-21.00%-47.20%
Leverage & Solvency Ratios
Debt/Equity0.020.100.050.040.030.02
Liquidity Ratios
Current Ratio17.505.2811.3613.5027.0416.73
Quick Ratio17.164.8210.9213.1026.5316.66
Efficiency Ratios
Asset Turnover---0.000.020.09
Yield & Distribution Ratios
Earnings Yield-13.19%-89.35%-24.86%-39.44%-7.88%-
FCF Yield-10.71%-80.64%-22.92%-35.02%-7.26%-
Buyback Yield-46.80%-5.51%-7.69%-93.84%-175.00%0.00%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Immuneering Financial Ratios

What is Immuneering's return on equity?

Immuneering's return on equity (ROE) was -43.1% for fiscal 2025 (period ended Dec 31, 2025). It was -92.5% a year earlier.

What is Immuneering's debt-to-equity ratio?

Immuneering's debt-to-equity ratio was 0.02 for fiscal 2025 (period ended Dec 31, 2025). It was 0.10 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition